Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Takeda pays $800m for US gout drug maker URL Pharma

This article was originally published in Scrip

Executive Summary

Takeda is to acquire the private US company URL Pharma, which makes gout drug Colcrys (colchicine), for $800 million. It will pay in cash, and has agreed to make additional payments based on future performance.



Related Companies